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The nasal histopathology of HTLV-1 carriers with chronic rhinitis is unknown.
Objective: To describe the histopathological features of HTLV-1 carriers with chronic rhinitis.
Materials and Methods: Biopsies of nasal mucosa of ten HTLV-1 carriers with chronic rhinitis 
(eight patients with allergic rhinitis and two patients with non-allergic rhinitis) were studied using 
a light microscope. Samples from ten patients with allergic rhinitis not infected with HTLV-1 were 
used as controls.
Results: Subepithelial fibrosis was more pronounced in patients with allergic rhinitis infected with 
HTLV-1 (p=0.01), while the basement membrane thickness was greater in controls (p=0.03). There was 
a trend towards less eosinophilia and edema among those infected with HTLV-1, without statistical 
significance (p=0.2). For the lymphocytic infiltrate, there was no difference between infected and not 
infected patients with allergic rhinitis (p=1.0). Subepithelial fibrosis associated to moderate or small 
number of lymphocytes were found in the two HTLV-1 carriers with non-allergic rhinitis.
Conclusions: This study suggests HTLV-1 may modify the histopathology of allergic rhinitis, 
especially by promoting subepithelial fibrosis, and may be related to chronic non-allergic rhinitis 
with lymphocytic infiltrate.
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INTRODUCTION
The Human T-lymphotropic Virus Type 1 (HTLV-1) 
is a human retrovirus with tropism for T-cells. Diseases 
such as adult T-cell leukemia and myelopathy are strongly 
associated with HTLV-1 infection1. Other inflammatory 
conditions including interstitial pneumonia and alveolar/
bronchial disorders related to HTLV-1, have been described 
in case reports1-3. However, most individuals infected by 
HTLV-1 are clinically asymptomatic and referred to as 
carriers.
While HTLV-1 infection is associated to lymphocytic 
infiltration in the involved tissues, rhinitis allergic - the 
most common type of chronic rhinitis - and asthma are 
characterized by eosinophilic infiltration of the nasal and 
bronchial mucosa respectively4,5. Although the histologic 
characteristics of the nasal mucosa of individuals with 
allergic rhinitis and concomitant infection by HTLV-1 are 
unknown, both HTLV-1 infection and respiratory allergic 
disease may be associated with fibrosis3,5.
Some HTLV-1 carriers present respiratory symptoms 
suggestive of chronic rhinitis, but the characteristics of the 
nasal mucosa of these patients are unknown. To know 
them, therefore, is most desirable, even more so in the city 
of Salvador in the Brazilian Northeast, where HTLV-1 sero-
prevalence is the highest in the nation: 1.76%6. Histologic 
analysis of these cases may assist in the investigation of 
the etiology of chronic rhinitis and of the possible influ-
ence of HTLV-1 upon allergic rhinitis. Thus, the purpose 
of this study is to describe histologic findings of the nasal 
mucosa of HTLV-1 carriers diagnosed with chronic rhinitis, 
and compare the histology of allergic rhinitis patients to 
that of subjects not infected by HTLV-1.
MATERIALS AND METHODS
Volunteers
This study was approved by our institution’s Ethics 
Committee and given permit number 09/2002; all partici-
pants signed an informed consent form.
Eight asymptomatic HTLV-1 carriers diagnosed with 
untreated perennial allergic rhinitis were recruited at the 
Multidisciplinary HTLV-1 Ward to undergo nasal biopsy. 
The diagnosis of perennial allergic rhinitis was produced 
from the analysis of each patient’s history and physical 
examination, supported by skin tests for local relevant 
aeroallergens. Additionally, two HTLV-1 carriers with 
chronic rhinitis of unknown etiology were analyzed; they 
were negative for local aeroallergens and their prevailing 
symptoms were nasal obstruction and coryza.
Patients with intestinal parasites, deviated nasal 
septum, nasal polyps, viral hepatitis, mycobacterium 
infection, smokers, and subjects taking steroids and/or 
immunosuppressants were excluded.
Surgical specimens from elective turbinectomy pa-
tients with allergic rhinitis and negative serology for HTLV-
1 were used as controls. Therefore, this was a sample of 
convenience. According to the institution’s procedures, the 
patients in this group used nasal topical steroids for three 
months before surgery and combined oral antihistamines 
for three weeks. These patients were kept on nasal steroids 
for ethical reasons, the same reason why patients without 
nasal complaints did not undergo nasal biopsy.
Nasal biopsy
The biopsy samples for HTLV-1 carriers with chronic 
rhinitis were obtained through the Fokkens modified7 
approach. Local anesthesia was done using a cotton ball 
soaked in 10% xylocaine and epinephrine (3 drops of 
1:1,000 solution) applied on the lower turbinate. Three 
samples were collected from each patient from the lower 
tip of the lower turbinate, 2 cm posteriorly to the anterior 
border, using a 2.5 mm Gerritsma forceps.
Morphology
Biopsy samples were fixated in 10% buffered for-
malin and embedded in paraffin. The 5μm slices were 
dyed in H&E, periodic acid-Schiff (PAS), and Sirius red, 
and were then observed in the light microscope by an 
experienced pathologist in a blinded fashion (EAR). 
Samples were categorized based on the method described 
by Shioda & Mishima (1966)8. Cell count was performed 
in a semi-quantitative manner by assessing lymphocytes 
and eosinophils as follows: ±, occasional cells; +, few 
cells; + +, moderate number of cells; + + +, large number 
of cells. The criterion to categorize subepithelial fibrosis, 
edema, and basement membrane thickening is as fol-
lows: 0, none; +, mild; + +, moderate; + + +, intense. For 
purposes of statistical analysis the grades were converted 
into a numeric scale, in that 0.5 is equal to ±, 1 being +, 
and so on and so forth. Epithelial lining was categorized 
as normal, foliated, or affected by squamous metaplasia.
Immunohistochemistry
Immunohistochemistry testing of inflammatory cells 
was done in two HTLV-1 carriers whose allergy tests were 
negative. The paraffin-embedded slices were analyzed us-
ing a panel of antibodies and the standard technique using 
streptavidin-biotin-peroxidase9. The following immunohis-
tochemistry markers were used: T-cell markers T CD45RO 
(UCHL-1), CD4 (OPD4); B-cell marker CD20; lymphoma 
marker CD30; and proliferation marker Ki-67 (MIB-1).
Statistical analysis
The Mann-Whitney test was used to compare mean 
ages, presence of lymphocytes, eosinophils, subepithelial 
fibrosis, basement membrane thickening, and nasal mu-
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cosa edema among HTLV-1 carriers with allergic rhinitis 
(case group) and patients with allergic rhinitis and nega-
tive serology for HTLV-1 (control group). Fisher’s test was 
used to analyze gender differences. For all tests statistical 
significance was attributed when p<0.05.
RESULTS
Three males and five females with allergic rhinitis 
and infected by HTLV-1 had ages ranging between 25 and 
55 years (mean 44.5). One 55-year-old female patient also 
had asthma. In the group of allergic rhinitis patients not 
infected by HTLV-1 (control group), five patients were 
males and five were females. Their ages ranged between 
22 and 56 years (mean 38.9). There was no statistically 
significant difference for gender and age among the pa-
tients with allergic rhinitis either infected or not by HTLV-1.
The two non-allergic rhinitis patients infected by 
HTLV-1 were males aged 36 and 42 years.
Nasal mucosa histology findings can be seen on 
Tables 1 and 2. The following histological variables pre-
sented statistically significant differences: degree of fibrosis, 
greater on HTLV-1 carriers with allergic rhinitis (p=0.01), 
as seen in the comparison between Figures 1 and 2; and 
basement membrane thickening, greater in the uninfected 
control group (p=0.03). HTLV-1 carriers tended to have 
less eosinophilia and edema, but the difference lacked 
statistical significance (p=0.2). There was no difference in 
terms of lymphocytic infiltrate between infected patients 
with allergic rhinitis and uninfected subjects (p=1.0). 
Epithelial lining alterations were similar for infected and 
uninfected patients.
Figure 3 shows mononuclear infiltrate with a pre-
dominant presence of lymphocytes in HTLV-1 carriers with 
non-allergic chronic rhinitis. Immunohistochemistry testing 
of the nasal mucosa of two HTLV-1 carriers with non-
Table 1. Semi-quantitative analysis of nasal mucosa histopathology findings of HTLV-1 carriers with allergic rhinitis and non-allergic 
rhinitis (*).
Patient
Lymphocytic 
infiltrate
Eosinophilic 
infiltrate
Subepithelial 
fibrosis
Edema
Basement membrane 
thickening
Epithelial lining
1 + + ++ + 0 Normal
2(*) ++ + +++ + + Normal
3 + ++ +++ + + Normal
4 + + +++ ++ + Normal
5(*) + + ++ 0 0 Normal
6 ++ + + + 0 Foliated
7 + + +++ 0 0 Squamous metaplasia
8 + + +++ + + Normal
9 + + +++ + + Normal
10 + + + 0 0 Foliated
(*) Patients negative for allergy skin test.
Figure 1. Intense subepithelial fibrosis in nasal mucosa of HTLV-1 
carrier with allergic rhinitis. Sirius Red, 400X.
Figure 2. Mild subepithelial fibrosis in nasal mucosa of patient with 
allergic rhinitis not infected by HTLV-1. Sirius Red, 400X.
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Table 2. Semi-quantitative analysis of nasal mucosa histopathology findings of patients with allergic rhinitis and negative serology 
for HTLV-1 (controls).
Patient
Lymphocytic 
infiltrate
Eosinophilic in-
filtrate
Subepithelial 
fibrosis
Edema
Basement membrane 
thickening
Epithelial lining
1 + +++ 0 +++ ++ Normal
2 ++ +++ + +++ ++ Normal
3 + + + + +++ Normal
4 + ± ++ 0 +++ Normal
5 + ++ + + + Normal
6 + ± + + 0 Foliated
7 + ± + + 0 Foliated
8 + ± + ++ + Normal
9 ++ + ++ + ++ Squamous Metaplasia
10 + +++ ++ + ++ Normal
Figure 3. Mononuclear infiltrate in nasal mucosa of HTLV-1 carrier with 
non-allergic rhinitis. HE, 400X.
allergic rhinitis was positive for T-cell markers CD45RO 
and CD4, with diffuse and focal distribution respectively. 
Samples were negative for CD20 (B-cell marker), CD30 
(lymphoma marker), and Ki-67 (proliferation marker).
DISCUSSION
Allergic rhinitis combined with HTLV-1 infection 
was associated with nasal mucosa subepithelial fibrosis in 
our study. Basement membrane thickening was observed 
at a greater degree in allergic rhinitis patients not infected 
by HTLV-1. Nasal mucosa subepithelial fibrosis was greater 
in HTLV-1 carriers with allergic rhinitis when compared 
to uninfected allergic rhinitis patients. The difference in 
the intensity of subepithelial fibrosis observed between 
the two groups cannot be explained solely by the anti-
inflammatory effect of the topical nasal steroids used by 
the control group, as such association is not established 
in the literature and the therapy was of short duration. 
For the patients with allergic rhinitis infected by HTLV-1, 
one must consider that both allergic rhinitis and HTLV-1 
infection may be potentially associated with the fibrosis of 
the involved tissues. On the other hand, it is not clear why 
subepithelial basement membrane thickening was lesser 
in the allergic rhinitis patients not infected by HTLV-1.
Montero et al. (2003) described basement mem-
brane thickening and nasal mucosa subepithelial fibrosis in 
92.3% and 92.4%, respectively, of individuals with allergic 
rhinitis5. Chronic inflammation associated with cytokines 
and mediators such as T-cell growth factor (TGF-β1) and 
granulocyte–macrophage colony-stimulating factor (GM-
CSF) may induce the activation and proliferation of fibro-
blasts, resulting in the deposition of collagen and other 
extracellular matrix products10. It has been considered 
that the morphologic remodeling phenomenon in allergic 
patients occurs less frequently in upper airways than in 
lower airways, as seen in asthma10.
The chronic inflammation associated with HTLV-1 
infection causes fibrosis to set in on the involved tissues. 
Patients with HTLV-1-related myelopathy have early lep-
tomeningeal fibrosis11. Airway alveolar fibrosis in HTLV-1 
carriers has been documented, but no studies have looked 
into the nasal mucosa of HTLV-1 carriers12.
HTLV-1 infection stimulates the production of 
GM-CSF, interferon gamma (IFN-γ), interleukin-2 (IL-2), 
tumor necrosis factor (TNF-α), immune response type 
1 cytokines, aside from IL-4, IL-5 and IL-1013. On type 2 
immune response, seen in allergic inflammation, there is 
increased production of IL-4, IL-5, and IL-1314. Type 1 and 
type 2 immune response may be mutually impacted both 
by contra-regulation and synergy15. Incidentally, the mu-
tual stimulation between immune responses may explain 
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the significant subepithelial fibrosis seen in patients with 
allergic rhinitis and HTLV-1 infection, while an inhibitory 
contra-regulatory effect may be implicated in the cell infil-
trate profile seen in the nasal mucosa of these individuals.
Concomitant HTLV-1 infection is associated with the 
scarce eosinophilia seen in the nasal mucosa of allergic 
rhinitis patients. This study showed a trend of less nasal 
eosinophilia in allergic rhinitis patients infected by HTLV-
1 when compared to uninfected allergic rhinitis patients 
treated with steroids. Therefore, this study indicates that 
HTLV-1 infection may affect nasal eosinophilia to the ex-
tent that the findings in this group is, at least, similar to the 
findings seen in some individuals who were supposedly 
affected by the therapeutic effect of steroids. Contrary to 
subepithelial fibrosis, the nasal eosinophilic infiltrate seen 
in patients with allergic rhinitis may be reduced after only 
four weeks of treatment with steroids16. In the infected 
group not treated with steroids, inhibitory regulation be-
tween the immune profiles of HTLV-1 infection and allergy 
may be responsible for the discrete eosinophilia seen in 
the nasal mucosa of these subjects.
Souza-Machado et al. (2005) found prevalence 
rates of atopy in HTLV-1 carriers of 14.9% against 29.7% 
in uninfected controls17. The diameter of the papules 
observed in the skin test was smaller in atopic HTLV-1 
carriers when compared to atopic uninfected controls17. 
Intercellular Adhesion Molecule 1 (ICAM-1) levels in the 
nasal fluid of HTLV-1 carriers with allergic rhinitis were 
lower than those observed on uninfected allergic rhinitis 
controls18. These data indicate that the immune response 
to HTLV-1 infection may modify allergic manifestations. 
This histologic study supports these observations and has 
found incipient eosinophilic infiltrate in HTLV-1 patients 
with allergic rhinitis.
The two HTLV-1 carriers with allergic rhinitis had 
mononuclear infiltrate with a predominant presence of T-
cells as confirmed by immunohistochemistry. Considering 
the thesis of the single airway19, it is plausible to suppose 
the existence of rhinitis associated with HTLV-1 analogous 
to bronchitis and lymphocytic pneumonia as described in 
HTLV-1 infection2,20,21,22,23. Lymphocytic infiltrate has been 
described in myelitis11, uveitis24, arthritis25, sialadenitis26, 
dermatitis27 and nephritis28 associated with HTLV-1 infec-
tion, but the possible existence of chronic allergic rhinitis 
not related to HTLV-1 requires further study and more 
case reports.
CONCLUSION
This study indicates that HTLV-1 infection may 
modify the nasal histopathology of allergic rhinitis. This 
paper indicates that the coexistence of allergic rhinitis 
and HTLV-1 infection on one same individual may be 
associated with increased subepithelial fibrosis, less thi-
ckening of the subepithelial basement membrane, and a 
trend towards scarce eosinophilia. Nonetheless, the role 
of allergy and HTLV-1 infection concomitant to fibrosis on 
nasal mucosa cell counts require better characterization 
in future studies. We do not know if fibrosis and nasal 
lymphocytic infiltrate seen in HTLV-1 carriers are a new 
entity within the realm of rhinitis.
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